Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 901–1,000 of 1,000
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression
Chen, C. H., Reva, B., Katabi, N., Wizel, A., Xu, H.-B., Ho, A. L., Morris, L. G. T., Bakst, R. L., Parikh, A. S., Drier, Y., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242250 · Cited by 12
Pan, L., Liu, C., Kong, Y., Piao, Z., & Cheng, B. (2017) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-162070 · Cited by 8
“As the (cid:2) -ARs present on many tumor cells become activated, the synthesis and release of pro-angiogenic factors (VEGF, IL-8, and IL-6) increases, leading to accelerated tumor growth [26, 27].”
Integrative Oncology: The Role of Complementary Medicine in Supportive Cancer Care
Deng, G. E., & Latte-Naor, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-90990-5_10 · Cited by 10
Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer
Mravec, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116115 · Cited by 9
Li, Y.-Z., Qin, X., Liu, F.-H., Chen, W.-X., Wei, Y., Wang, N., Yan, S., Kang, Y., Zhao, Y., Gao, S., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247394 · Cited by 8
“An animal experiment has validated that chronic stress can result in higher levels of tissue catecholamines, greater tumor burden, and more invasive growth of OC [44].”
BackgroundSelf-citationNucleolar organizer regions in a chronic stress and oral cancer model
RUZ, I. A. M., Droguett, D., TORRES, W. K. D., Kemmerling, U., Rojas, B. V., & MARTÍNEZ, C. A. R. (2011) · Oncology Letters · doi:10.3892/ol.2011.514 · Cited by 9
“A number of studies have demonstrated a positive association between stress and cancer (1,2).”
BackgroundJacobsen, K. R., Jørgensen, P. S., Pipper, C. B., Steffensen, A. M., Hau, J., & Abelson, K. (2013) · PubMed · Cited by 10
Walker, W. H., Kvadas, R. M., May, L. E., Liu, J. A., Bumgarner, J. R., Walton, J., Devries, A. C., Dauchy, R., Blask, D., & Nelson, R. (2021) · Cancers · doi:10.3390/cancers13194860 · Cited by 8
“However, increased tumor measurements would likely increase stress, which has demonstrated detrimental effects on both study outcomes [70,71].”
BackgroundThe effect of surgical wound on ovarian carcinoma growth in an animal model.
Lee, J., Park, Y.-A., Cho, Y., Kang, K.-H., Choi, J., Lee, Y.-Y., Kim, T., Choi, C. H., Kim, B., & Bae, D. (2013) · PubMed · Cited by 8
Self-citationCartland, S. P., Lin, R. C. Y., Genner, S. W., Patil, M. S., Martínez, G. J., Barraclough, J., Gloss, B., Misra, A., Patel, S., & Kavurma, M. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902785r · Cited by 9
Blair, A. B., Jurcak, N. R., Javed, A. A., Teinor, J. A., Groot, V. P., Rozich, N., Cameron, J. L., Weiss, M. J., He, J. P., Wolfgang, C. L., et al. (2020) · Annals of Pancreatic Cancer · doi:10.21037/apc-19-45 · Cited by 7
Harðardóttir, H., Aspelund, T., Fall, K., Broström, E., Sigurdsson, B. B., Cook, E., Valdimarsdottir, H. B., Fang, F., Sloan, E. K., Lutgendorf, S. K., et al. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2258445 · Cited by 7
“Growing preclinical and clinical evidence from recent literature [10,12,13,21] supports that SNS activation facilitates multiple aspects of tumor progression.”
BackgroundSelf-citationNervous system–gut microbiota–immune system axis: future directions for preventing tumor
Wang, J., Cheng, W., & Yang, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535955 · Cited by 11
“…system (CNS) and the peripheral nervous system, plays a role in the progression of various cancers such as gastric, colon, rectal, oral squamous cell, head and neck, prostate, breast, and pancreatic cancers (3), and that the autonomic nerve contributes to prostate cancer progression (25 – 29).”
Ge, M., Zhang, W., Zhang, W., Zhang, Z., Zeng, X., Deng, L., Wen, M., Lu, X., Shen, X., Li, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.001 · Cited by 10
“VIP also induces NO production via the PI3K–AKT–eNOS pathway, resulting in vasodilation and further facilitating endothelial cell motility[50,147].”
Liu, Y., Gu, R., Gao, M., Wei, Y., Shi, Y., Wang, X., Gu, Y.-H., Gu, X., & Zhang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1126271 · Cited by 9
“Isoproterenol, an a-adrenergic agonist, can imitate the tumor growth and angiogenesis brought on by prolonged stress, while propranolol, an a-adrenergic antagonist, can prevent this (61).”
BackgroundPriyanka, H. P., Pratap, U. P., Nair, R. S., Vasantharekha, R., & ThyagaRajan, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02322-8 · Cited by 7
“Chronic stress may contribute to an environment conducive to tumor growth and metastasis, although the mechanisms involved are complex [21].”
Attia, Y. M., Hakeem, A. N., Samir, R., Mohammed, A., Elsayed, A., Khallaf, A., Essam, E., Amin, H., Abdullah, S., Hikmat, S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1362675 · Cited by 7
“Increased sympathetic drive induced by chronic restraint stress was found to promote angiogenesis in TNBC tumor-bearing mice (Thaker et al., 2006).”
BackgroundStress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer
Sun, X., Teper, Y., Sinnett‐Smith, J. W., Markarian, M., Hines, O. J., Li, G., Eibl, G., & Rozengurt, E. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0785 · Cited by 7
Perceived association of mood and symptom severity in adults with mitochondrial diseases
Kelly, C. A., Cross, M., Junker, A., Englestad, K., Rosales, X. Q., Hirano, M., Trumpff, C., & Picard, M. A. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102033 · Cited by 8
Beyond Alkylating Agents for Gliomas: Quo Vadimus ?
Puduvalli, V. K., Chaudhary, R. T., McClugage, S. G., & Markert, J. M. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175003 · Cited by 7
Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor
Liu, S., Li, B., Li, J., Sun, S., Sun, S., & Wu, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.896147 · Cited by 12
“, β-adrenergic receptors (ARs) stimulated by norepinephrine (NE), is a major mechanism by which stress can enhance tumor development and increase vascularization (Thaker et al., 2006).”
BackgroundHeym, M., Heiland, M., Preißner, R., Hübel, C., Nahles, S., Schmidt‐Westhausen, A. M., Preißner, S., & Hertel, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1080492 · Cited by 7
Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
Zhang, B., Zhang, L., Qi, P., Pang, R., Wang, Z., Liu, X., Shi, Q., & Zhang, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-32733-y · Cited by 7
Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
Ventura, S., & Evans, B. A. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.114 · Cited by 7
Flint, M. S., McCarty, K. S., Jenkins, F. J., Conrads, T. P., Sun, M., & Baum, A. E. (2010) · Stress and Health · doi:10.1002/smi.1343 · Cited by 7
Sun, N., Zang, W., & Li, W. (2012) · PubMed · Cited by 7
Systematic Quantification of GPCR/cAMP-Controlled Protein Kinase A Interactions
Torres‐Quesada, O., Röck, R., & Stefan, E. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-110791 · Cited by 8
Eroğlu, O., Kaya, H., Çelik, E. G., Celen, M., Korkut, E., & NİZAM, N. (2019) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2019.72007 · Cited by 7
“Previous studies exhibited propranolol’s effect on pre-clinic models of both ovarian and breast cancers which are induced by stress to inhibit metastasis however it can only affect the growth of primary tumor of ovarian cancer model [31] [32] [33].”
BackgroundHorváthová, Ľ., Tillinger, A., Padová, A., Bízik, J., & Mravec, B. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14661 · Cited by 7
“There are many papers discussing the concept of stress and cancer (Cao & During, 2012; Montgomery & Patterson, 2006; Thaker et al., 2006; Volden & Conzen, 2013).”
BackgroundCange, C. W. (2016) · Medicine Conflict & Survival · doi:10.1080/13623699.2016.1269284 · Cited by 7
“Breast cancer is one particular condition that shows a link between chronic stress accumulation and carcinogenesis (Jacobs and Bovasso 2000; Thaker et al. 2006).”
BackgroundPsychoneuroimmunology of Cancer – Recent Findings and Perspectives
Mravec, B., Tibenský, M., & Horváthová, Ľ. (2018) · Klinicka onkologie · doi:10.14735/amko2018345 · Cited by 8
Isolating the Effects of Social Interactions on Cancer Biology
Trainor, B. C., Sweeney, C. A., & Cardiff, R. D. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0167 · Cited by 8
“Although corticosterone is a prime candidate mechanism linking experience to cancer biology, previous studies have shown that βadrenergic receptors play an important role in mediating the effects of stress on ovarian carcinoma (12).”
BackgroundInfluentialComplementary and Alternative Medicine and Cancer Survivorship
Huntley, A. L., de Valois, B. A., Dog, T. L., & Borrelli, F. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/850429 · Cited by 8
Li, P., Liang, M., Zhu, J., Chen, J., Xia, L., Jin, Z., Zhang, X., Zhang, S., Wang, Q., Liu, Z., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107696 · Cited by 6
Huang, S., Lei, D., Yang, L., Bi, A., Wang, Y., Zhang, P., Zhuang, D., Liu, H., Cai, Q., Nie, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202413580 · Cited by 7
Zhang, Z., Ren, S., Fan, X., Chen, H., Chen, J., Wang, X., Zong, H., Zhang, S., Zhao, T., Sun, Y., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106118 · Cited by 8
Wang, X., Deng, Y., Zheng, P., Sun, X., Sun, Y., Sun, L., Dai, H., Bi, H., Feng, K., Ma, K., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07288-z · Cited by 6
“Another study identified that β-adrenergic activation of the cAMP–PKA signaling pathway is a major mechanism by which behavioral stress can increase tumor angiogenesis in vivo, thereby promote ovarian cancer growth [34].”
Chronic stress in cancer development and progression
Niu, X., Wu, T. H., Zeng, L., Wang, F., Lv, W., Zhang, L., & Zhou, F. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.09.034 · Cited by 12
Research progress on chronic stress stimulation and gastric cancer metastasis
Chen, J., Zhang, Y., Zhang, T., Wen, Z., Li, Y., Ye, Y., Zhou, Z., & Jia, G. (2025) · Discover Oncology · doi:10.1007/s12672-025-03950-w · Cited by 7
“Animal studies have demonstrated that in a chronic restraint stress mouse model, the use of the ADRB2 antagonist propranolol significantly reduces tumor metastasis [64].”
Self-citationNew highlights in cancer and depression multimorbidity: a scoping systematic review
Tang, L., Li, D., & Wu, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1674653 · Cited by 6
“Norepinephrine and epinephrine bind to b -adrenergic receptors, activating downstream pathways such as p38 MAPK, which contributes to abnormal cancer cell proliferation (67, 68).”
Li, G., Li, F., Tang, Y., Guo, S., Yao, Y., Yuan, F., Zhang, B., Jiang, Y. Y., Wang, J., Wu, D., et al. (2025) · MedComm · doi:10.1002/mco2.70556 · Cited by 7
Glinin, T. S., Petrova, M. V., Shcherbinina, V., Shubina, A., Dukelskaya, A. V., Starshova, P., Mamontova, V., Burnusuz, A., Godunova, A. O., Romashchenko, A. V., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44647-w · Cited by 7
“Moreover, genome destabilization is considered to be a hallmark of aging, a risk factor for tumorigenesis 55 and neuropsychiatric conditions 56 , and is thought to be one the main causes of age-related hematopoietic stem cell pool exhaustion 54 leading to subsequent impairment in hemato-and…”
BackgroundChristian, L. M., Kiecolt‐Glaser, J. K., Cole, S. W., Burd, C. E., Madison, A. A., Wilson, S. J., & Rosko, A. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.019 · Cited by 8
“The consequent β -adrenergic signaling promotes inflammation, which induces IL-6 production and overproduction of vascular endothelial growth factor (VEGF) (Bierhaus et al., 2003; Thaker et al., 2006; Cole et al., 2010).”
BackgroundSelf-citationCancer Development and Progression in Patients with Heart Failure
Seuthe, K., Picard, F. S. R., Winkels, H., & Pfister, R. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00680-y · Cited by 8
“In a mouse model of ovarian cancer, Thaker et al. [49] reported that stress-induced catecholamines promoted tumour growth, invasiveness, and vascularization by enhancing the expression of VEGF as the central mediator of neoangiogenesis.”
BackgroundDuan, Y., Lin, J., Yue, J., Li, Y., Liao, J., Sun, Y., Wang, Q., Duan, Y., & Li, Z. (2024) · Science China Materials · doi:10.1007/s40843-024-3095-8 · Cited by 7
“Moreover, VEGFA stimulates the expression of MMP2 and MMP9, matrix metalloproteinases critical for neovascularization [13].”
Self-citationDash, S., Yoder, S., Mesa, T., Smith, A., Cen, L., Eschrich, S. A., Armaiz-Peña, G. N., & Monteiro, Á. N. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93506-z · Cited by 7
Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer
Liu, M., Zhou, X., Sun, L., Tan, S., Liu, T., Xiao, W., & Tang, J. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112935 · Cited by 6
Inequities in the Impacts of Hurricanes and Other Extreme Weather Events for Cancer Survivors
Gudenkauf, L. M., Hathaway, C. A., Carroll, J., Small, B. J., Li, X., Hoogland, A. I., Castro, E., Armaiz-Peña, G. N., Oswald, L. B., Jim, H., et al. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-1029 · Cited by 6
Cardiovascular MRI in small animals
Makowski, M. R., Wiethoff, A. J., Jansen, C. H. P., & Botnar, R. M. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.126 · Cited by 6
Mustafa, S., Ennab, W., Korejo, N. A., Wei, Q., Lv, Z., Shi, Z., & Shi, F. (2020) · Animals · doi:10.3390/ani10010122 · Cited by 6
“Experimental animal studies indicate that prolonged stress increases the risk of many health problems, including neuropsychiatric disorders [39], type 2 diabetes [40], and tumorigenesis [41].”
BackgroundНавратилова, М. (2020) · Psychiatrie pro praxi · doi:10.36290/psy.2020.015 · Cited by 6
Zhou, Q., Katano, M., Zhang, J.-H., Liu, X., Wang, K., Iinuma, M., Kubo, K., & Azuma, K. (2021) · Brain Sciences · doi:10.3390/brainsci11040479 · Cited by 6
“Glucocorticoid and norepinephrine levels are i creased in individu ls with acute or chronic psychologic str ss [4,10,11,13,37].”
BackgroundDepression's Impact on Survival in Patients With Cancer
Boyajian, R. N. (2010) · Clinical journal of oncology nursing · doi:10.1188/10.cjon.649-652 · Cited by 6
“…Bagley, & Lippman, 1988), an increase in catecholamines (Lutgendorf et al., 2005), and the release of angiogenic cytokines promoting angiogenesis (Irwin, Clark, Kennedy, Christian Gillin, & Ziegler, 2003), all of which are associated with tumor growth and cancer progression (Thaker et al., 2006).”
BackgroundSüleyman, H., Çadırcı, E., Albayrak, A., Halıcı, Z., Gündoğdu, C., & Hacımüftüoğlu, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24869 · Cited by 6
The Cellular Microenvironment and Metastases
Rankin, E. B., Erler, J. T., & Giaccia, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00003-5 · Cited by 9
Psychoneuro-oncology: Its Time Has Arrived
Smith, N., Fuhrmann, T., & Tausk, F. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.306 · Cited by 6
Chronic stress and oral cancer research: Disregarded aspects in animal model studies
Anand, R., Sarode, G. S., & Sarode, S. C. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2015.12.010 · Cited by 6
“Chronic stress has been shown to interfere immune function and is thought to play a role in the etiology of tumor growth [2].”
Wu, Y., Zhang, Y., Shi, X., Wu, M., Sun, M., Feng, Y., Ma, W., Jiang, X., Fei, D., Zhao, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci195685 · Cited by 7
“Preclinical studies using chronic restraint or social isolation in mice, 2 well-established chronic stress models, also support the notion that chronic stress promotes cancer initiation and progression (4–6).”
Pinheiro, A. V., Petrucci, G. N., Dourado, A., & Pires, I. C. R. (2023) · Animals · doi:10.3390/ani13213392 · Cited by 7
“Considering the immune system as a main player in the body’s defence against tumour growth, some human and animal studies suggest a new approach to minimising the impact on the immune cells of several suppressive factors such as stress, pain, anaesthesia and surgery [19,44,45].”
BackgroundCancer Builds a Noxious Partnership with Psychologic Stress
Magnon, C. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0628 · Cited by 6
Luo, P., Tong, K., Gan, Y., Tang, M., Niu, Y., Liu, K., Ni, S., Wu, S., Jiang, X., Jiang, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202502421 · Cited by 7
Anti- Metastatic Gene Therapy in Patients with Advanced Epithelial Ovarian Cancer (EOC)
Farghaly, S. A. (2013) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.s15-001 · Cited by 6
“These catecholamines have been shown to increase tumor cell proliferation [40], adhesion [41], migration [42] and invasion [43].”
BackgroundCai, K., Han, D., Deng, D., Ke, M., Peng, M., Lyu, J., & Xu, A. (2022) · Cancer Control · doi:10.1177/10732748221143388 · Cited by 5
“major histocompatibility complex class-I and class-II molecules, and reduce natural-killer cells activity, and ultimately accelerating tumor progression and increasing LGG-specific mortality.(25,26) In our study, the SD and CS models showed that patients with LGG in the temporal/parietal/overlapping lobes had worse pr…”
BackgroundBeyond genetics: integrative oncology and the metabolic perspective on cancer treatment
Nair, P. M. K., Silwal, K., Ramalakshmi, R., Devibala, M., Saranya, M., Sivaranjani, S., Ramasamy, T., Palanisamy, A., & Mahalingam, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1455022 · Cited by 5
Gangliosides and Antigangliosides in Malignant Melanoma
Ene, C. D., & Nicolae, I. (2015) · InTech eBooks · doi:10.5772/59176 · Cited by 9
Bodnarchuk, T. W., Stavrou, S., & Gantefoer, A. (2014) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2014.02.001 · Cited by 5
“A study by Thaker et al [10] reported that both tumor growth and angiogenesis were also up-regulated by chronic stress in a mouse model.”
BackgroundRavoori, M. K., Han, L., Singh, S. P., Dixon, K. A., Duggal, J., Liu, P., Uthamanthil, R., Gupta, S. K., Wright, K. C., & Kundra, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062371 · Cited by 5
“Anatomic in vivo imaging, such as CT or MR [11,14–16], can measure tumor size and characterize morphology [14,18,30,34].”
MethodSelf-citationOliveira, D. T., Bravo-Calderón, D. M., Lauand, G. A., Assáo, A., Peñaranda, J. M. S., Pérez‐Sayáns, M., Garcı́a, A. G., Marana, A. N., Nonogaki, S., Lauris, J. R. P., et al. (2016) · Journal of Oncology · doi:10.1155/2016/3531274 · Cited by 5
Cancer chemotherapy failure: a synthetic view
Junqueira, M. Z., & Chammas, R. J. (2018) · Revista de Medicina · doi:10.11606/issn.1679-9836.v97i2p141-153 · Cited by 5
Feline Anxiety and Fear-Related Disorders
Stepita, M. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-22652-3.00090-6 · Cited by 5
Propofol-TIVA versus inhalational anesthesia for cancer surgery
Edwards, Z. E., & Kelliher, L. (2020) · Digestive Medicine Research · doi:10.21037/dmr-20-58 · Cited by 5
“The final mechanism proposed is that tissue trauma caused during surgery results in the release of potent angiogenic factors (VEGF and prostaglandin E2) coupled with a reduction in the levels of anti-angiogenic factors like angiostatin and endostatin (14).”
BackgroundEvaluation of In-vivo Anticancer Activity Choerospondias axillaris in Swiss Albino Mice Models
Elyasi, Z., Rajashekhar, U., Jha, D. K., & Khadka, J. (2022) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2022/v34i54a7237 · Cited by 5
Depression and Quality of Life in Patients with Neurological Disorder in a Malaysian Hospital
Das, P., Naing, N. N., Wan‐Arfah, N., Jan, K. N. N., Kueh, Y. C., & Rasalingam, K. (2019) · East Asian Archives of Psychiatry · doi:10.12809/eaap1777 · Cited by 5
Nguyen, H. T., Jia, W. P., Beedle, A. M., Kennedy, E. J., & Murph, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139489 · Cited by 5
“This reinforces the role of ATF3 and intimates an important contextual function among patients with ovarian cancer, especially since stress promotes the progression of ovarian cancer [16].”
BackgroundElucidating the mechanisms of psychosocial influences on cancer using preclinical in vivo models
Sloan, E. K., & Walker, A. K. (2019) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2019.02.007 · Cited by 6
Targeting the Architecture of Deregulated Protein Complexes in Cancer
Stefan, E., Troppmair, J., & Bister, K. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.07.001 · Cited by 7
Health, Stress, and Social Networks: Evidence from Union Army Veterans
Costa, D. L., & Kahn, M. E. (2008) · National Bureau of Economic Research · doi:10.3386/w14053 · Cited by 5
Cosentino, M., Marino, F., & Lecchini, S. (2009) · Blood · doi:10.1182/blood-2009-04-216275 · Cited by 5
Chronic stress-related neuroendocrine mediators and ovarian cancer
Du, H., Yu, G., Hu, R., Du, J., & Liu, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-04012-x · Cited by 4
“…brown fat cells and human ovarian cancer cells have shown that NE and isoproterenol (a β-adrenergic receptor agonist) can induce the expression of VEGF, which is mainly mediated by the ADRB/cyclic adenosine mono-phosphate (cAMP)/PKA signaling pathway, which process promotes tumor growth [27– 29].”
Association of social isolation and loneliness with cancer prognosis: an analysis of the UK Biobank
Liu, Q., Zhao, Y., Xue, H., Wang, Y., Wei, H., & Liu, Q. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121049 · Cited by 4
Liu, H., Li, M., Lin, Y., You, H., Kou, J., & Feng, W. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5601 · Cited by 4
“Tumorigenesis and tumor progression may be mediated by angiogenic processes, such as the increase of vascularization and upregulation of VEGF, MMP‑2 and MMP‑9 (11,42).”
BackgroundSelf-citationPinheiro, A. V., Petrucci, G. N., Dourado, A., Silva, F. C., & Pires, I. C. R. (2024) · Cancers · doi:10.3390/cancers16173015 · Cited by 6
“In oncologic patients undergoing surgery, the main risk of tumor dissemination occurs in the perioperative period [5,6], during which stress [7], pain [8], anesthetic and Cancers 2024 , 16 , 3015 2 of 19 analgesic agents [9,10], and surgical procedures influence the immune and tumor cellular…”
BackgroundBeta‐blockers and epithelial ovarian cancer survival: A Norwegian population‐based cohort study
Löfling, L., Støer, N. C., Sloan, E. K., Nafisi, S., Fortner, R. T., & Botteri, E. (2025) · International Journal of Cancer · doi:10.1002/ijc.35348 · Cited by 5
“8 11 β -blocker medications have been used to treat cardiovascular conditions, including hypertension, since the 1960s.”
Tiwari, R. K., Rawat, S. G., Rai, S., & Kumar, A. (2025) · Endocrine · doi:10.1007/s12020-025-04161-7 · Cited by 6
“Further, β -adrenoreceptor-mediated activation of the cAMP-PKA signaling pathway has been identi fi ed as a crucial player in stress-enhanced tumor angiogenesis [248].”
InfluentialXu, C., Huo, D., Liu, Y., Zhu, Q., Zhao, J., Liang, J., & Wang, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14980-6 · Cited by 4
“…renal tubular apoptosis via glucocorticoid receptor-dependent pathways [17], while sympathetic catecholamine surges activate the HIF-2α/VEGF pro-angiogenic pathway in tumor micro-environments through β-adrenergic receptor-dependent mechanisms, synergistically promoting KC pathogenesis [18, 19].”
Li, R., Chen, J., Chen, Y., Jin, K., Chen, Y., Deng, C., Liu, X., & Li, Y. (2025) · Journal of International Medical Research · doi:10.1177/03000605251397839 · Cited by 5
Self-citationMeng, W., Li, M., Ren, R., Mu, X., Hou, B., & Li, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1848277 · Cited by 4
“Seminal mechanistic studies demonstrated that chronic adrenergic stimulation enhances angiogenesis, matrix remodeling and metastatic dissemination through the cAMP-PKA axis and downstream effectors (VEGF, MMPs, HIF-1 α ) in tumor cells (Thaker et al., 2006).”
García-Laguna, G., Gerena-Cruz, M. F., Sánchez, A. Y., Monroy-Gómez, J. A., & Dueñas, Z. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113399 · Cited by 4
Rowe, J., Ferguson, T. D., & Krigolson, O. E. (2021) · The Arbutus Review · doi:10.18357/tar121202120178 · Cited by 5
Carneiro, É. M., Oliveira, L. F. A., da Silva, D. A. A., Catarino, J. D. S., Timóteo, R. P., Desidério, C. S., Rodrigues, V., & Borges, M. D. F. (2022) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2020-0305 · Cited by 7
Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework
Chow, P. I., Roller, D. G., Boukhechba, M., Shaffer, K. M., Ritterband, L. M., Reilley, M. J., Le, T. M., Kunk, P. R., Bauer, T. W., & Gioeli, D. G. (2023) · Internet Interventions · doi:10.1016/j.invent.2023.100644 · Cited by 4
“Literature in cancer has documented a robust association between people's health behaviors and their tumor progression (Robertson et al., 2016; Sklar and Anisman, 1979; Thaker et al., 2006).”
BackgroundLi, Z., Huang, Z., Wang, Z., Guo, Z., Wang, B., Li, Y., & Xu, E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1644315 · Cited by 7
“Additionally, chronic stress can induce the release of catecholamines through the sympathetic nervous system, activating the β -adrenergic receptor signaling pathway and promoting angiogenesis and tumor cell proliferation (Thaker et al., 2006; Zhang et al., 2019).”
Self-citationEpigenetic Regulation in Biopsychosocial Pathways
Litzelman, K., & Verma, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_29 · Cited by 4
Mechanisms of Metastasis of Solid Organ Tumors in the Perioperative Period
Freeman, J. A., Connolly, C. M., & Buggy, D. J. (2016) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000124 · Cited by 4
“In a number of studies, the activation of tumor cell beta-adrenoceptors promoted the spread of metastases through the increased expression of prometastatic factors and facilitation of angiogenesis.(63,64) Surgery-induced changes also occur in the patient’s cellular and cytokine milieu.”
BackgroundStress resilience and survival among cancer patients: is there any absolute truth?
Mormile, R. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03853-y · Cited by 4
Liu, Y., Zou, L., Wang, P., Zhou, J., Yuan, C., & Wang, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9794 · Cited by 6
Anti-proliferative effects of beta-blocker propranolol on human lung cancer and noncancer cells
Terzi, M. Y., & Küçük, M. U. (2023) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2023_045 · Cited by 12
Lv, L., Zhao, J., WANG, X., XU, L., FAN, Y., WANG, C., Fan, H., & PEI, X. (2023) · Biocell · doi:10.32604/biocell.2023.030742 · Cited by 5
Major Stressful Life Events and the Risk of Pancreatic, Head and Neck Cancers: A Case–Control Study
Sridhar, A., Sekhon, V. K., Nguyen, C., Abushalha, K., Tahanan, A., Rahbar, M. H., & Jafri, S. H. (2024) · Cancers · doi:10.3390/cancers16020451 · Cited by 4
“In vivo studies have hypothesized that that chronic stress affects tumor angiogenesis by the chronic release of proangiogenic factors (e.g., VEGF, IL-6, TGF-α and - β and TNF-α ) and causes immune suppression, which can increase the risk of cancer development [19,20].”
BackgroundPennington, K. P., Schlumbrecht, M., McGregor, B. A., Goodheart, M. J., Heron, L., Zimmerman, B., Telles, R., Zia, S., Penedo, F. J., & Lutgendorf, S. K. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107612 · Cited by 3
Self-citation
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.